Assura PLC Director/PDMR Shareholding

RNS Number : 4155H

Assura PLC

08 October 2024

 

8 October 2024

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 7 October 2024 the following named PDMRs acquired partnership shares and were awarded matching shares and free shares over ordinary shares of 10 pence each in the Company under the Company's Share Incentive Plan ("SIP").

PDMR	Position	Number of partnership shares acquired	Number of matching shares awarded	Shareholding of PDMR and PCAs post acquisition and award
Jonathan Murphy	CEO	357	416	3,325,589
Jayne Cottam	CFO	357	416	950,733
Orla Ball	General Counsel	357	416	37,432
Robert James	Group Development Director	358	419	28,660
Sarah Taylor	Chief People Officer	360	420	17,922

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jonathan Murphy
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 10 pence each           GB00BVGBWW93
b)	Nature of the transaction	Acquisition of partnership shares and award of matching shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s)   £0.4183 GBP     773
d)	Aggregated information   -      Aggregated volume   -    Price	Aggregate Price Aggregate Volume Aggregate Total   £0.4183 GBP     773   £323.35 GBP
e)	Date of the transaction	7 October 2024
f)	Place of the transaction	XLON

 

 

 

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 10 pence each           GB00BVGBWW93
b)	Nature of the transaction	Acquisition of partnership shares and award of matching shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s)   £0.4183 GBP     773
d)	Aggregated information   -      Aggregated volume   -    Price	Aggregate Price Aggregate Volume Aggregate Total   £0.4183 GBP     773   £323.35 GBP
e)	Date of the transaction	7 October 2024
f)	Place of the transaction	XLON

 

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Orla Ball
2	Reason for the notification
a)	Position/status	General Counsel
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 10 pence each           GB00BVGBWW93
b)	Nature of the transaction	Acquisition of partnership shares and award of matching shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s)   £0.4183 GBP     773
d)	Aggregated information   -      Aggregated volume   -    Price	Aggregate Price Aggregate Volume Aggregate Total   £0.4183 GBP     773   £323.35 GBP
e)	Date of the transaction	7 October 2024
f)	Place of the transaction	XLON

 

 

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Robert James
2	Reason for the notification
a)	Position/status	Group Development Director
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 10 pence each           GB00BVGBWW93
b)	Nature of the transaction	Acquisition of partnership shares and award of matching shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s)   £0.4183 GBP     777
d)	Aggregated information   -      Aggregated volume   -    Price	Aggregate Price Aggregate Volume Aggregate Total   £0.4183 GBP     777   £325.02 GBP
e)	Date of the transaction	7 October 2024
f)	Place of the transaction	XLON

 

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Sarah Taylor
2	Reason for the notification
a)	Position/status	Chief People Officer
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 10 pence each           GB00BVGBWW93
b)	Nature of the transaction	Acquisition of partnership shares and award of matching shares under the SIP
c)	Price(s) and volume(s)	Price(s) Volume(s)   £0.4183 GBP     780
d)	Aggregated information   -      Aggregated volume   -    Price	Aggregate Price Aggregate Volume Aggregate Total   £0.4183 GBP     780   £326.27 GBP
e)	Date of the transaction	7 October 2024
f)	Place of the transaction	XLON

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, General Counsel David Purcell, Investor Relations Director	Email: [e-mail]
FGS Global Gordon Simpson	Tel: [phone] Email: [e-mail]

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHBUBDGIBGDGSI